JP2013049634A - Acne treatment agent - Google Patents
Acne treatment agent Download PDFInfo
- Publication number
- JP2013049634A JP2013049634A JP2011186845A JP2011186845A JP2013049634A JP 2013049634 A JP2013049634 A JP 2013049634A JP 2011186845 A JP2011186845 A JP 2011186845A JP 2011186845 A JP2011186845 A JP 2011186845A JP 2013049634 A JP2013049634 A JP 2013049634A
- Authority
- JP
- Japan
- Prior art keywords
- acne
- extract
- vitamin
- derivative
- carrot
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract description 44
- 206010000496 acne Diseases 0.000 title claims abstract description 44
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 59
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 23
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 23
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 23
- 239000011718 vitamin C Substances 0.000 claims abstract description 23
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 12
- 235000020710 ginseng extract Nutrition 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 9
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 claims description 7
- 230000000694 effects Effects 0.000 abstract description 33
- 239000000284 extract Substances 0.000 abstract description 23
- 244000000626 Daucus carota Species 0.000 abstract description 19
- 235000002767 Daucus carota Nutrition 0.000 abstract description 19
- 108010063907 Glutathione Reductase Proteins 0.000 abstract description 17
- 102100036442 Glutathione reductase, mitochondrial Human genes 0.000 abstract description 17
- 208000002193 Pain Diseases 0.000 abstract description 13
- 230000001939 inductive effect Effects 0.000 abstract description 7
- 230000002708 enhancing effect Effects 0.000 abstract description 4
- 235000002789 Panax ginseng Nutrition 0.000 abstract description 3
- 240000004371 Panax ginseng Species 0.000 abstract 2
- 239000000203 mixture Substances 0.000 description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- -1 ascorbic acid phosphate ester Chemical class 0.000 description 20
- 238000004519 manufacturing process Methods 0.000 description 19
- 239000006210 lotion Substances 0.000 description 17
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 16
- 238000009472 formulation Methods 0.000 description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 15
- 241000208340 Araliaceae Species 0.000 description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 210000003491 skin Anatomy 0.000 description 11
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 10
- 235000003140 Panax quinquefolius Nutrition 0.000 description 10
- 235000008434 ginseng Nutrition 0.000 description 10
- 229910019142 PO4 Inorganic materials 0.000 description 9
- 235000010323 ascorbic acid Nutrition 0.000 description 9
- 239000011668 ascorbic acid Substances 0.000 description 9
- 229960005070 ascorbic acid Drugs 0.000 description 9
- 239000003921 oil Substances 0.000 description 9
- 235000019198 oils Nutrition 0.000 description 9
- 239000010452 phosphate Substances 0.000 description 9
- 239000008213 purified water Substances 0.000 description 9
- 229940058015 1,3-butylene glycol Drugs 0.000 description 8
- 239000008346 aqueous phase Substances 0.000 description 8
- 235000019437 butane-1,3-diol Nutrition 0.000 description 8
- 230000006872 improvement Effects 0.000 description 8
- 230000001965 increasing effect Effects 0.000 description 8
- 239000012071 phase Substances 0.000 description 8
- 239000003205 fragrance Substances 0.000 description 7
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 7
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 6
- 239000003963 antioxidant agent Substances 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 229940008396 carrot extract Drugs 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 230000003834 intracellular effect Effects 0.000 description 5
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 5
- 235000010378 sodium ascorbate Nutrition 0.000 description 5
- 229960005055 sodium ascorbate Drugs 0.000 description 5
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 150000003700 vitamin C derivatives Chemical class 0.000 description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- 108010024636 Glutathione Proteins 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 239000000469 ethanolic extract Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000012488 sample solution Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 108010053070 Glutathione Disulfide Proteins 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 229960003180 glutathione Drugs 0.000 description 3
- YPZRWBKMTBYPTK-BJDJZHNGSA-N glutathione disulfide Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(O)=O)CSSC[C@@H](C(=O)NCC(O)=O)NC(=O)CC[C@H](N)C(O)=O YPZRWBKMTBYPTK-BJDJZHNGSA-N 0.000 description 3
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- YPZRWBKMTBYPTK-UHFFFAOYSA-N oxidized gamma-L-glutamyl-L-cysteinylglycine Natural products OC(=O)C(N)CCC(=O)NC(C(=O)NCC(O)=O)CSSCC(C(=O)NCC(O)=O)NC(=O)CCC(N)C(O)=O YPZRWBKMTBYPTK-UHFFFAOYSA-N 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- 230000001603 reducing effect Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241000207199 Citrus Species 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 235000020971 citrus fruits Nutrition 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 2
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 210000003780 hair follicle Anatomy 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 239000004922 lacquer Substances 0.000 description 2
- 229940074358 magnesium ascorbate Drugs 0.000 description 2
- AIOKQVJVNPDJKA-ZZMNMWMASA-L magnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2h-furan-3-olate Chemical compound [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] AIOKQVJVNPDJKA-ZZMNMWMASA-L 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 208000035824 paresthesia Diseases 0.000 description 2
- 239000008055 phosphate buffer solution Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 239000004129 EU approved improving agent Substances 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229940124091 Keratolytic Drugs 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical class NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 235000002791 Panax Nutrition 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical class CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 1
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000000637 arginyl group Chemical class N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
- 239000013040 bath agent Substances 0.000 description 1
- 239000003788 bath preparation Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 210000005175 epidermal keratinocyte Anatomy 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 230000001530 keratinolytic effect Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Abstract
Description
本発明は、ビタミンC又はその誘導体と、サンシチニンジン抽出物とを含有することを特徴とするニキビ改善剤及びニキビ改善用皮膚外用剤に関する。 [Technical Field] The present invention relates to an acne improving agent and a skin external preparation for improving acne, characterized by containing vitamin C or a derivative thereof and a sancinin ginseng extract.
ニキビとは、様々な原因により引き起こされる皮膚の炎症性疾患で、医学的には尋常性ざ瘡と呼ばれる。主に皮脂腺の多い顔、頭、胸、背中に多く発症する。ニキビの発症には、皮脂分泌過剰、毛嚢角化、毛嚢内細菌が重要な役割を果たしつつ、種々の要因が複雑に絡み合っていると考えられている。したがって、ニキビ治療用の外用剤としては、皮脂分泌抑制成分、角質溶解成分、消炎成分及び抗菌物質を配合したクリームや軟膏が一般に多く用いられている。 Acne is an inflammatory disease of the skin caused by various causes and is medically called acne vulgaris. It occurs mainly on the face, head, chest, and back with many sebaceous glands. Various factors are thought to be intricately intertwined with the development of acne, with excessive sebum secretion, keratinization of hair follicles, and bacteria in hair follicles playing important roles. Therefore, as an external preparation for acne treatment, creams and ointments containing a sebum secretion inhibiting component, a keratolytic component, an anti-inflammatory component and an antibacterial substance are generally used.
近年、ビタミンC類を含有する製剤で処置することにより、臨床的にニキビの改善効果がみられることが明らかになってきた(特許文献1)。ビタミンC類は、強力な還元作用を有する抗酸化成分であることから、ニキビの改善に皮膚の酸化防御が有効であると考えられるが、ビタミンC類の高濃度化によりニキビの改善効果を高めることには、ビタミンC類に起因するスティンギングが誘発されやすくなるという問題があり、実用的ではない。スティンギングとは、化粧品等を塗布した際に、一過性に感じるヒリヒリ感やチクチク感のことであり、これによりその化粧品等の使用を中止せざるを得ない場合も少なくない。そこで、ビタミンC類の高濃度化以外にニキビの改善効果を高める手段の開発が望まれていた。 In recent years, it has been clarified that treatment with a preparation containing vitamin Cs has an effect of improving acne clinically (Patent Document 1). Since vitamin C is an antioxidant component having a strong reducing action, it is considered that oxidative protection of the skin is effective in improving acne. However, increasing the concentration of vitamin C increases the effect of improving acne. There is a problem that stinging due to vitamin C is likely to be induced, which is not practical. Stinging is a tingling or tingling sensation that is felt temporarily when a cosmetic or the like is applied, and there are many cases in which the use of the cosmetic or the like must be stopped. Therefore, it has been desired to develop a means for improving the acne improvement effect in addition to increasing the concentration of vitamin Cs.
一方、グルタチオンとは、グルタミン酸、システイン、グリシンからなるトリペプチドであり、細胞内に存在する抗酸化成分である。グルタチオンは、電子供与体として作用することによって還元作用を示すが、このプロセスにおいて酸化型グルタチオンに変換される。酸化型グルタチオンは、グルタチオンレダクターゼの作用により還元型グルタチオンに変換され、再度、還元作用を示すようになる。すなわち、細胞内のグルタチオンレダクターゼ活性を高めることは、細胞の抗酸化レベルを高めることにつながると考えられ、グルタチオンレダクターゼ活性増強剤が開示されている(特許文献2)。 On the other hand, glutathione is a tripeptide composed of glutamic acid, cysteine, and glycine, and is an antioxidant component present in cells. Glutathione exhibits a reducing action by acting as an electron donor, but is converted to oxidized glutathione in this process. Oxidized glutathione is converted to reduced glutathione by the action of glutathione reductase, and again exhibits a reducing action. That is, increasing the intracellular glutathione reductase activity is thought to lead to an increase in the antioxidant level of the cell, and a glutathione reductase activity enhancer has been disclosed (Patent Document 2).
近年、サンシチニンジン抽出物についての研究が進められ、コラーゲン合成促進剤(特許文献3)、毛髪育成用組成物(特許文献4)が開示されているが、サンシチニンジン抽出物のグルタチオンレダクターゼ活性増強作用及びニキビ改善作用は報告されていない。 In recent years, research on the extract of sanchinin ginseng has been promoted, and a collagen synthesis accelerator (patent document 3) and a composition for hair growth (patent document 4) have been disclosed. The glutathione reductase activity of the sancinin carrot extract is disclosed. An enhancing action and an acne improving action have not been reported.
ビタミンC又はその誘導体単独でのニキビ改善効果は、低濃度では充分なものではなく、高濃度では効果は高まるもののスティンギング誘発という問題があった。本発明は、スティンギングを誘発することなく、高い効果を有するニキビ改善剤及びニキビ改善用皮膚外用剤を提供することを課題とする。 The acne improvement effect of vitamin C or its derivative alone is not sufficient at a low concentration, but the effect is increased at a high concentration, but there is a problem of stinging induction. An object of the present invention is to provide an acne improving agent and a skin external preparation for improving acne having high effects without inducing stinging.
本発明者は、この問題点を解決すべく鋭意研究を重ねた結果、皮膚細胞内のグルタチオンレダクターゼ活性を亢進し細胞の抗酸化レベルを高めることがニキビの改善に有用であることを見出した。また、ビタミンC又はその誘導体と、グルタチオンレダクターゼ活性増強剤とを併用することにより、スティンギングを誘発することなく、相乗的にニキビ改善効果を増強することができること、さらにサンシチニンジン抽出物がグルタチオンレダクターゼ活性増強作用を発揮することを発見し、本発明を完成するに至った。 As a result of intensive studies to solve this problem, the present inventor has found that it is useful for improving acne to enhance glutathione reductase activity in skin cells and increase the antioxidant level of cells. In addition, the combined use of vitamin C or a derivative thereof and a glutathione reductase activity enhancer can synergistically enhance the acne-improving effect without inducing stinging, and the extract of sanchinin ginseng is glutathione. It has been found that the reductase activity enhancing action is exerted, and the present invention has been completed.
本発明は、ビタミンC又はその誘導体と、サンシチニンジン抽出物とを含有することを特徴とするニキビ改善剤及びニキビ改善用皮膚外用剤である。 The present invention is an acne ameliorating agent and a skin external preparation for acne amelioration characterized by containing vitamin C or a derivative thereof and a sancinin ginseng extract.
本発明のビタミンC又はその誘導体と、サンシチニンジン抽出物とを併せて用いることにより、スティンギングを誘発することなく、相乗的にニキビの改善効果を高めることができる。 By using the vitamin C of the present invention or a derivative thereof in combination with the sancinin ginseng extract, the acne improvement effect can be synergistically enhanced without inducing stinging.
本発明でいうビタミンC又はその誘導体としては特に限定されず、例えば、アスコルビン酸、アスコルビン酸のリン酸エステル、アスコルビン酸の脂肪酸エステル、アスコルビン酸グルコシド等のアスコルビン酸の配糖体及びそれらの塩等を挙げることができる。塩としては、ナトリウム塩、カリウム塩等のアルカリ金属塩、カルシウム塩、マグネシウム塩等のアルカリ土類金属塩、アンモニウム塩、トリエタノールアミン塩、トリエチルアミン塩等の有機アミン塩類、リジン塩、アルギニン塩等の塩基性アミノ酸塩が好ましい。これらのビタミンC又はその誘導体のうち、特に好ましいものは、アスコルビン酸又はアスコルビン酸リン酸エステル、及びそれらの塩である。これらは一種を用いることもできるし、二種以上を組み合わせて用いることもできる。 Vitamin C or a derivative thereof in the present invention is not particularly limited, and examples thereof include ascorbic acid, ascorbic acid phosphate ester, ascorbic acid fatty acid ester, ascorbic acid glucoside and other ascorbic acid glycosides and salts thereof, and the like. Can be mentioned. Examples of the salt include alkali metal salts such as sodium salt and potassium salt, alkaline earth metal salts such as calcium salt and magnesium salt, organic amine salts such as ammonium salt, triethanolamine salt and triethylamine salt, lysine salt, arginine salt and the like The basic amino acid salt of Among these vitamin C or derivatives thereof, particularly preferred are ascorbic acid or ascorbic acid phosphate ester and salts thereof. These may be used alone or in combination of two or more.
本発明でいうサンシチニンジンは、ウコギ科ニンジン属に属し、学名Panax noto−ginsengである。中国南部雲南省近郊の標高約1500mの高山の斜面で栽培され、漢方薬として、止血、滋養強壮薬に用いられる。生薬としては、三七人参、田七人参、三七、田七、山漆、金不換等の名称があり、製造方法の違いから、根をそのまま乾燥した三七人参、田七人参と、蒸気で蒸して加熱処理をしてから乾燥した熟三七人参、熟田七人参等に大別できる。 The Sancytin carrot as referred to in the present invention belongs to the genus Carrot family and has the scientific name Panax not-ginseng. It is cultivated on an alpine slope at an altitude of about 1500m near Yunnan Province in southern China, and is used as a herbal medicine for hemostasis and nutritional tonic. Herbal medicines have names such as 37 ginseng, red ginseng, thirty seven, seven seven, ginseng lacquer, gold lacquer, etc. Steamed and heat-treated and then dried roughly, it can be broadly divided into ripening ginseng and ginseng ginseng.
本発明に用いるサンシチニンジン抽出物とは、植物体の葉、茎、花、果実、種子、根等の植物体の一部又は全草から抽出した物である。好ましくは根から抽出して得られるものがよい。これは三七人参の名称で市販されているので、それを利用することができる。 The sancytin carrot extract used in the present invention is a product extracted from a part of the plant body such as leaves, stems, flowers, fruits, seeds and roots of the plant body or whole plant. What is obtained by extracting from a root is preferable. This is marketed under the name of Ginseng, so you can use it.
本発明のサンシチニンジンの抽出方法は特に限定されず、例えば、加熱抽出したものであっても良いし、常温又は低温で抽出したものであっても良い。
抽出する溶媒としては、例えば、水、低級アルコール類(メタノール、エタノール、1−プロパノール、2−プロパノール、1−ブタノール、2−ブタノール等)、液状多価アルコール(1,3−ブチレングリコール、プロピレングリコール、グリセリン等)、ケトン類(アセトン、メチルエチルケトン等)、アセトニトリル、エステル類(酢酸エチル、酢酸ブチル等)、炭化水素類(ヘキサン、ヘプタン、流動パラフィン等)、エーテル類(エチルエーテル、テトラヒドロフラン、プロピルエーテル等)が挙げられる。好ましくは、水、低級アルコール及び液状多価アルコール等の極性溶媒が良く、特に好ましくは、水、エタノール、1,3−ブチレングリコール及びプロピレングリコールが良い。これらの溶媒は1種でも2種以上を混合して用いても良い。
The extraction method of the sancinin ginseng of this invention is not specifically limited, For example, what was extracted by heating may be used, and what was extracted at normal temperature or low temperature may be used.
Examples of the solvent to be extracted include water, lower alcohols (methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, etc.), liquid polyhydric alcohols (1,3-butylene glycol, propylene glycol). , Glycerin, etc.), ketones (acetone, methyl ethyl ketone, etc.), acetonitrile, esters (ethyl acetate, butyl acetate, etc.), hydrocarbons (hexane, heptane, liquid paraffin, etc.), ethers (ethyl ether, tetrahydrofuran, propyl ether) Etc.). Preferred are polar solvents such as water, lower alcohols and liquid polyhydric alcohols, and particularly preferred are water, ethanol, 1,3-butylene glycol and propylene glycol. These solvents may be used alone or in combination of two or more.
上記抽出物は、抽出した溶液のまま用いても良く、必要に応じて、濃縮、希釈、濾過、活性炭等による脱色、脱臭等の処理をして用いても良い。さらには、抽出した溶液を濃縮乾固、噴霧乾燥、凍結乾燥等の処理を行い、乾燥物として用いても良いし、カラム精製等を行って有効成分を濃縮したり、単離して用いても良い。 The extract may be used as it is, or may be used after concentration, dilution, filtration, decolorization with activated carbon, deodorization, or the like, if necessary. Furthermore, the extracted solution may be used as a dried product after being concentrated, dried, spray-dried, freeze-dried, etc., or the active ingredient may be concentrated or isolated by column purification. good.
本発明のビタミンC又はその誘導体と、サンシチニンジン抽出物とを含有することを特徴とするニキビ改善剤を用いるには、通常外用により投与される。投与量は、年齢、体重、症状、治療効果、投与方法、処理時間等により異なるが、通常成人1人当たり1回に1mg〜5000mg、好ましくは5mg〜1000mg、より好ましくは20mg〜200mgの範囲で1日1回から数回投与される。投与量は種々の条件で変動するので、上記投与範囲より少ない量で十分な場合もあるし、範囲を超えて投与する必要のある場合もある。 In order to use an acne ameliorating agent characterized by containing vitamin C of the present invention or a derivative thereof and a sancinin ginseng extract, it is usually administered by external use. The dose varies depending on age, body weight, symptoms, therapeutic effect, administration method, treatment time, etc., but is usually 1 mg to 5000 mg, preferably 5 mg to 1000 mg, more preferably 20 mg to 200 mg per adult. It is administered once to several times a day. Since the dosage varies depending on various conditions, an amount smaller than the above dosage range may be sufficient, or it may be necessary to administer beyond the range.
本発明のビタミンC又はその誘導体と、サンシチニンジン抽出物とを含有することを特徴とするニキビ改善剤は、化粧品、医薬部外品及び医薬品のいずれにも用いることができ、その剤型としては、例えば、化粧水、クリーム、乳液、ゲル剤、エアゾール剤、軟膏、パップ剤、ペースト剤、プラスター剤、エッセンス、パック、洗浄剤、浴用剤、ファンデーション、打粉、口紅等の皮膚に適用されるものが挙げられる。ビタミンC又はその誘導体と上記抽出物をそのまま使用しても良く、それらの効果を損なわない範囲内で、外用剤に用いられる成分である油脂類、ロウ類、炭化水素類、脂肪酸類、アルコール類、エステル類、界面活性剤、金属石鹸、pH調整剤、防腐剤、香料、保湿剤、増粘剤、色素、酸化防止剤、キレート剤等の成分を配合することができる。 The acne-improving agent characterized by containing vitamin C of the present invention or a derivative thereof and a sancinin ginseng extract can be used for any of cosmetics, quasi-drugs, and pharmaceuticals. Is applied to skin such as lotion, cream, emulsion, gel, aerosol, ointment, poultice, paste, plaster, essence, pack, cleaning agent, bath preparation, foundation, powder, lipstick, etc. Things. Fats and oils, waxes, hydrocarbons, fatty acids, alcohols that are components used in external preparations may be used as they are, as long as vitamin C or a derivative thereof and the above extract may be used as they are. , Esters, surfactants, metal soaps, pH adjusters, preservatives, fragrances, moisturizers, thickeners, pigments, antioxidants, chelating agents, and the like can be blended.
本発明に用いるビタミンC又はその誘導体の配合量は、本発明のビタミンC又はその誘導体と、サンシチニンジン抽出物とを含有することを特徴とするニキビ改善剤の全量に対し、固形物に換算して0.0001重量%以上、好ましくは0.001〜5重量%の配合が良い。0.0001重量%未満では充分な効果は望みにくい。5重量%を超えて配合した場合、スティンギングを誘発しやすくなる。また、添加の方法については、予め加えておいても、製造途中で添加しても良く、作業性を考えて適宜選択すれば良い。 The compounding amount of vitamin C or a derivative thereof used in the present invention is converted into a solid with respect to the total amount of the acne improver characterized by containing the vitamin C of the present invention or a derivative thereof and a sanchinin ginseng extract. Therefore, 0.0001% by weight or more, preferably 0.001 to 5% by weight is good. If it is less than 0.0001% by weight, a sufficient effect is hardly expected. When it exceeds 5% by weight, stinging tends to be induced. In addition, the addition method may be added in advance or during the production, and may be appropriately selected in consideration of workability.
本発明に用いるサンシチニンジン抽出物の配合量は、本発明のビタミンC又はその誘導体と、サンシチニンジン抽出物とを含有することを特徴とするニキビ改善剤の全量に対し、固形物に換算して0.0001重量%以上、好ましくは0.001〜50重量%の配合が良い。0.0001重量%未満では充分な効果は望みにくい。50重量%を超えて配合した場合、効果の増強はみられにくく不経済である。また、添加の方法については、予め加えておいても、製造途中で添加しても良く、作業性を考えて適宜選択すれば良い。 The compounding amount of the citrus carrot extract used in the present invention is converted into a solid with respect to the total amount of the acne improving agent characterized by containing the vitamin C of the present invention or a derivative thereof and the sancinin carrot extract. Therefore, 0.0001% by weight or more, preferably 0.001 to 50% by weight is good. If it is less than 0.0001% by weight, a sufficient effect is hardly expected. When it exceeds 50% by weight, it is uneconomical that the effect is hardly increased. In addition, the addition method may be added in advance or during the production, and may be appropriately selected in consideration of workability.
本発明を詳細に説明するため、実施例として本発明に用いる抽出物の製造例、ニキビ改善剤又はニキビ改善用皮膚外用剤の処方例及び実験例を挙げるが、本発明はこれらに限定されるものではない。 In order to explain the present invention in detail, examples of the production of the extract used in the present invention, formulation examples and experimental examples of acne improving agents or skin external preparations for improving acne are given as examples, but the present invention is limited to these examples. It is not a thing.
製造例1 サンシチニンジンの熱水抽出物
サンシチニンジンの根の乾燥物を細かく切断し、40gに800mLの水を加えた後に95〜100℃で2時間抽出した。得られた抽出液を濾過し、濃縮した後に凍結乾燥してサンシチニンジンの熱水抽出物7.5gを得た。
Manufacture example 1 The hot water extract of a sanchinin carrot The dried material of the root of the sanchinin carrot was cut | disconnected finely, and after adding 800 mL water to 40g, it extracted at 95-100 degreeC for 2 hours. The obtained extract was filtered, concentrated, and freeze-dried to obtain 7.5 g of a hot water extract of sanchinin carrot.
製造例2 サンシチニンジンの50%エタノール抽出物
サンシチニンジンの根の乾燥物を細かく切断し、100gに500mLの水及び500mLのエタノールを加えた後に常温で7日間抽出した。得られた抽出液を濾過した後に濃縮乾固してサンシチニンジンの50%エタノール抽出物9.8gを得た。
Production Example 2 Sancithin Carrot 50% Ethanol Extract A dried product of Sanci carrot root was cut into small pieces, 500 mL of water and 500 mL of ethanol were added to 100 g, and extracted at room temperature for 7 days. The obtained extract was filtered and then concentrated to dryness to obtain 9.8 g of a 50% ethanol extract of sanchinin carrot.
製造例3 サンシチニンジンの50%1,3−ブチレングリコール抽出物
サンシチニンジンの葉及び茎の乾燥物を細かく切断し、20gに1,3−ブチレングリコールの50重量%水溶液を200g加え、常温で7日間抽出した。抽出後、その抽出液を濾過してサンシチニンジンの50%1,3−ブチレングリコール抽出物160gを得た。
Manufacture example 3 50% 1,3-butylene glycol extract of sanchinin carrot The dried product of leaves and stems of sanchinin carrot was cut finely, and 200 g of a 50 wt% aqueous solution of 1,3-butylene glycol was added to 20 g. For 7 days. After the extraction, the extract was filtered to obtain 160 g of a 50% 1,3-butylene glycol extract of sanchinin carrot.
本発明のビタミンC又はその誘導体と、サンシチニンジン抽出物とを含有することを特徴とするニキビ改善剤又はニキビ改善用皮膚外用剤の処方例として下記の製剤化を行うことができる。 The following formulation can be performed as a formulation example of an acne ameliorating agent or a skin external preparation for acne amelioration characterized by containing vitamin C of the present invention or a derivative thereof and a sancinin ginseng extract.
処方例1 化粧水1
成分 配合量(重量%)
1.アスコルビン酸リン酸ナトリウム 1.0
2.サンシチニンジンの熱水抽出物(製造例1) 0.1
3.1,3−ブチレングリコール 8.0
4.グリセリン 2.0
5.キサンタンガム 0.02
6.クエン酸 0.01
7.クエン酸ナトリウム 0.1
8.エタノール 5.0
9.パラオキシ安息香酸メチル 0.1
10.ポリオキシエチレン硬化ヒマシ油(40E.O.) 0.1
11.香料 0.1
12.精製水 83.47
[製造方法]成分1〜7及び12と、成分8〜11をそれぞれ均一に溶解し、両者を混合し濾過して製品とする。
Formulation Example 1 Lotion 1
Ingredient Amount (wt%)
1. Sodium ascorbate phosphate 1.0
2. Sancithin carrot hot water extract (Production Example 1) 0.1
3. 1,3-butylene glycol 8.0
4). Glycerin 2.0
5. Xanthan gum 0.02
6). Citric acid 0.01
7). Sodium citrate 0.1
8). Ethanol 5.0
9. Methyl paraoxybenzoate 0.1
10. Polyoxyethylene hydrogenated castor oil (40E.O.) 0.1
11. Fragrance 0.1
12 Purified water 83.47
[Production method] Components 1 to 7 and 12 and components 8 to 11 are uniformly dissolved, and both are mixed and filtered to obtain a product.
比較例1 従来の化粧水1
処方例1において、サンシチニンジンの熱水抽出物を精製水に置き換えたものを従来の化粧水1とした。
Comparative Example 1 Conventional lotion 1
In Formulation Example 1, a conventional lotion 1 was obtained by substituting purified water for the hot water extract of sancinin ginseng.
比較例2 従来の化粧水2
処方例1において、アスコルビン酸リン酸ナトリウムを精製水に置き換えたものを従来の化粧水2とした。
Comparative Example 2 Conventional lotion 2
In Formulation Example 1, a conventional lotion 2 was obtained by replacing sodium ascorbate phosphate with purified water.
比較例3 従来の化粧水3
成分 配合量(重量%)
1.アスコルビン酸リン酸ナトリウム 6.0
2.1,3−ブチレングリコール 8.0
3.グリセリン 2.0
4.キサンタンガム 0.02
5.クエン酸 0.01
6.クエン酸ナトリウム 0.1
7.エタノール 5.0
8.パラオキシ安息香酸メチル 0.1
9.ポリオキシエチレン硬化ヒマシ油(40E.O.) 0.1
10.香料 0.1
11.精製水 78.57
[製造方法]成分1〜6及び11と、成分7〜10をそれぞれ均一に溶解し、両者を混合し濾過して製品とする。
Comparative Example 3 Conventional lotion 3
Ingredient Amount (wt%)
1. Sodium ascorbate phosphate 6.0
2. 1,3-butylene glycol 8.0
3. Glycerin 2.0
4). Xanthan gum 0.02
5. Citric acid 0.01
6). Sodium citrate 0.1
7). Ethanol 5.0
8). Methyl paraoxybenzoate 0.1
9. Polyoxyethylene hydrogenated castor oil (40E.O.) 0.1
10. Fragrance 0.1
11. Purified water 78.57
[Production method] Components 1 to 6 and 11 and components 7 to 10 are uniformly dissolved, and both are mixed and filtered to obtain a product.
比較例4 従来の化粧水4
処方例1において、アスコルビン酸リン酸ナトリウム及びサンシチニンジンの熱水抽出物を精製水に置き換えたものを従来の化粧水4とした。
Comparative Example 4 Conventional lotion 4
In Formulation Example 1, conventional lotion 4 was obtained by replacing the hot water extract of sodium ascorbate phosphate and sancinin ginseng with purified water.
処方例2 クリーム
成分 配合量(重量%)
1.アスコルビン酸リン酸マグネシウム 0.5
2.サンシチニンジンの50%エタノール抽出物
(製造例2) 0.1
3.スクワラン 5.5
4.オリーブ油 3.0
5.ステアリン酸 2.0
6.ミツロウ 2.0
7.ミリスチン酸オクチルドデシル 3.5
8.ポリオキシエチレンセチルエーテル(20E.O.) 3.0
9.ベヘニルアルコール 1.5
10.モノステアリン酸グリセリン 2.5
11.香料 0.1
12.1,3−ブチレングリコール 8.5
13.パラオキシ安息香酸エチル 0.05
14.パラオキシ安息香酸メチル 0.2
15.精製水 67.55
[製造方法]成分3〜10を加熱して混合し、70℃に保ち油相とする。成分12〜15を加熱溶解して混合し、75℃に保ち水相とする。油相に水相を加えて乳化して、かき混ぜながら冷却し、45℃で成分11を加え、更に30℃まで冷却して成分1及び2を加え、製品とする。
Formulation Example 2 Cream component Formulation amount (% by weight)
1. Magnesium ascorbate phosphate 0.5
2. 50% ethanol extract of sanchinin carrot
(Production Example 2) 0.1
3. Squalane 5.5
4). Olive oil 3.0
5. Stearic acid 2.0
6). Beeswax 2.0
7). Octyldodecyl myristate 3.5
8). Polyoxyethylene cetyl ether (20E.O.) 3.0
9. Behenyl alcohol 1.5
10. Glycerol monostearate2.5
11. Fragrance 0.1
12.1,3-Butylene glycol 8.5
13. Ethyl paraoxybenzoate 0.05
14 Methyl paraoxybenzoate 0.2
15. Purified water 67.55
[Manufacturing method] Components 3 to 10 are heated and mixed to maintain an oil phase at 70 ° C. Ingredients 12 to 15 are dissolved by heating and mixed, and kept at 75 ° C. to form an aqueous phase. The aqueous phase is added to the oil phase to emulsify, and the mixture is cooled while stirring. Component 11 is added at 45 ° C., and the mixture is further cooled to 30 ° C. and components 1 and 2 are added to obtain a product.
処方例3 乳液
成分 配合量(重量%)
1.アスコルビン酸 0.5
2.サンシチニンジンの50%1,3−ブチレン
グリコール抽出物(製造例3) 0.05
3.スクワラン 5.0
4.オリーブ油 5.0
5.ホホバ油 5.0
6.セタノール 1.5
7.モノステアリン酸グリセリン 2.0
8.ポリオキシエチレンセチルエーテル(20E.O.) 3.0
9.ポリオキシエチレンソルビタンモノオレエート 2.0
10.香料 0.1
11.プロピレングリコール 1.0
12.グリセリン 2.0
13.パラオキシ安息香酸メチル 0.2
14.精製水 72.65
[製造方法]成分3〜9を加熱溶解して混合し、70℃に保ち油相とする。成分11〜14を加熱溶解して混合し、75℃に保ち水相とする。油相に水相を加えて乳化して、かき混ぜながら冷却し、45℃で成分10を加え、更に30℃まで冷却して成分1及び2を加え、製品とする。
Formulation Example 3 Emulsion component amount (% by weight)
1. Ascorbic acid 0.5
2. 50% 1,3-butylene of sanchinin carrot
Glycol extract (Production Example 3) 0.05
3. Squalane 5.0
4). Olive oil 5.0
5. Jojoba oil 5.0
6). Cetanol 1.5
7). Glycerol monostearate 2.0
8). Polyoxyethylene cetyl ether (20E.O.) 3.0
9. Polyoxyethylene sorbitan monooleate 2.0
10. Fragrance 0.1
11. Propylene glycol 1.0
12 Glycerin 2.0
13. Methyl paraoxybenzoate 0.2
14 Purified water 72.65
[Manufacturing method] Components 3 to 9 are dissolved by heating and mixed, and kept at 70 ° C to obtain an oil phase. Ingredients 11-14 are dissolved by heating and mixed, and kept at 75 ° C. to form an aqueous phase. The aqueous phase is added to the oil phase to emulsify, and the mixture is cooled with stirring. Then, component 10 is added at 45 ° C, and further cooled to 30 ° C, and components 1 and 2 are added to obtain a product.
処方例4 軟膏
成分 配合量(重量%)
1.アスコルビン酸リン酸ナトリウム 1.0
2.サンシチニンジンの熱水抽出物(製造例1) 1.0
3.ポリオキシエチレンセチルエーテル(30E.O.) 2.0
4.モノステアリン酸グリセリン 10.0
5.流動パラフィン 5.0
6.セタノール 6.0
7.パラオキシ安息香酸メチル 0.1
8.プロピレングリコール 10.0
9.精製水 64.9
[製造方法]成分3〜6を加熱溶解して混合し、70℃に保ち油相とする。成分1、2及び7〜9を加熱溶解して混合し、75℃に保ち水相とする。油相に水相を加えて乳化して、かき混ぜながら30℃まで冷却して製品とする。
Formulation Example 4 Ointment component Amount (% by weight)
1. Sodium ascorbate phosphate 1.0
2. Sancitin carrot hot water extract (Production Example 1) 1.0
3. Polyoxyethylene cetyl ether (30E.O.) 2.0
4). Glycerol monostearate 10.0
5. Liquid paraffin 5.0
6). Cetanol 6.0
7). Methyl paraoxybenzoate 0.1
8). Propylene glycol 10.0
9. Purified water 64.9
[Production Method] Components 3 to 6 are dissolved by heating and mixed, and kept at 70 ° C. to obtain an oil phase. Ingredients 1, 2, and 7-9 are dissolved by heating and mixed, and kept at 75 ° C. to form an aqueous phase. The aqueous phase is added to the oil phase to emulsify, and the mixture is cooled to 30 ° C. with stirring to obtain a product.
処方例5 ファンデーション
成分 配合量(重量%)
1.アスコルビン酸リン酸マグネシウム 1.0
2.サンシチニンジンの熱水抽出物(製造例1) 1.0
3.ステアリン酸 2.4
4.ポリオキシエチレンソルビタンモノステアレート
(20E.O.) 1.0
5.ポリオキシエチレンセチルエーテル(20E.O.) 2.0
6.セタノール 1.0
7.液状ラノリン 2.0
8.流動パラフィン 3.0
9.ミリスチン酸イソプロピル 6.5
10.パラオキシ安息香酸ブチル 0.1
11.カルボキシメチルセルロースナトリウム 0.1
12.ベントナイト 0.5
13.プロピレングリコール 4.0
14.トリエタノールアミン 1.1
15.パラオキシ安息香酸メチル 0.2
16.二酸化チタン 8.0
17.タルク 4.0
18.ベンガラ 1.0
19.黄酸化鉄 2.0
20.香料 0.1
21.精製水 59.0
[製造方法]成分3〜10を加熱溶解し、80℃に保ち油相とする。成分21に成分11をよく膨潤させ、続いて、成分1、2及び12〜15を加えて均一に混合する。これに粉砕機で粉砕混合した成分16〜19を加え、ホモミキサーで撹拌し75℃に保ち水相とする。この水相に油相をかき混ぜながら加え、冷却し、45℃で成分20を加え、かき混ぜながら30℃まで冷却して製品とする。
Formulation Example 5 Foundation component Amount (% by weight)
1. Magnesium ascorbate phosphate 1.0
2. Sancitin carrot hot water extract (Production Example 1) 1.0
3. Stearic acid 2.4
4). Polyoxyethylene sorbitan monostearate
(20 EO) 1.0
5. Polyoxyethylene cetyl ether (20E.O.) 2.0
6). Cetanol 1.0
7). Liquid lanolin 2.0
8). Liquid paraffin 3.0
9. Isopropyl myristate 6.5
10. Butyl paraoxybenzoate 0.1
11. Sodium carboxymethylcellulose 0.1
12 Bentonite 0.5
13. Propylene glycol 4.0
14 Triethanolamine 1.1
15. Methyl paraoxybenzoate 0.2
16. Titanium dioxide 8.0
17. Talc 4.0
18. Bengala 1.0
19. Yellow iron oxide 2.0
20. Fragrance 0.1
21. Purified water 59.0
[Production method] Components 3 to 10 are heated and dissolved, and kept at 80 ° C to obtain an oil phase. Swell component 11 well in component 21, then add components 1, 2 and 12-15 and mix uniformly. To this, components 16 to 19 pulverized and mixed with a pulverizer are added, and the mixture is stirred with a homomixer and kept at 75 ° C. to obtain an aqueous phase. The oil phase is added to this aqueous phase with stirring, cooled, component 20 is added at 45 ° C., and cooled to 30 ° C. with stirring to give a product.
処方例6 浴用剤
成分 配合量(重量%)
1.アスコルビン酸 2.0
2.サンシチニンジンの50%エタノール抽出物
(製造例2) 5.0
3.炭酸水素ナトリウム 50.0
4.黄色202号(1) 0.05
5.香料 0.25
6.無水硫酸ナトリウム 42.7
[製造方法]成分1〜6を均一に混合し製品とする。
Formulation Example 6 Bath agent component Formulation amount (% by weight)
1. Ascorbic acid 2.0
2. 50% ethanol extract of sanchinin carrot
(Production Example 2) 5.0
3. Sodium bicarbonate 50.0
4). Yellow No. 202 (1) 0.05
5. Fragrance 0.25
6). Anhydrous sodium sulfate 42.7
[Production Method] Components 1 to 6 are uniformly mixed to obtain a product.
以下、本発明を効果的に説明するために、実験例を挙げる。なお、本発明はこれにより限定されるものではない。 In order to effectively explain the present invention, experimental examples are given below. In addition, this invention is not limited by this.
実験例1 細胞内グルタチオンレダクターゼの活性化試験
細胞内グルタチオンレダクターゼの活性化効果を下記の条件にて測定した。
Experimental Example 1 Activation Test of Intracellular Glutathione Reductase The activation effect of intracellular glutathione reductase was measured under the following conditions.
コンフルエントな状態のヒト表皮角化細胞を、1μg/mLの試料を含むDMEM培地でさらに24時間培養した後、細胞を剥離し、1mMEDTAを含む50mMリン酸緩衝液(pH7.5)1mLを加えて超音波破砕し、15,000rpmで15分間遠心分離を行い、上清を試料溶液とした。試料溶液900μLに、9.5mM酸化型グルタチオン/リン酸緩衝溶液100μL及び2mMNADPH/リン酸緩衝溶液120μLを加え、340nmの吸光度の時間変化(φA340nm/min、3分間)を測定し、標準のグルタチオンレダクターゼ0、5、10及び20mU/mLから作成した検量線より試料溶液のグルタチオンレダクターゼ活性を算出した。同時に、試料溶液のタンパク濃度を測定し、単位タンパク当りのグルタチオンレダクターゼ活性を算出した。試料未添加の細胞のグルタチオンレダクターゼ活性をコントロールとし、コントロールを100としたときの試料添加のグルタチオンレダクターゼ活性の値を以下の数1により算出し、細胞内グルタチオンレダクターゼ活性とした。 Confluent human epidermal keratinocytes were further cultured in DMEM medium containing 1 μg / mL sample for 24 hours, then the cells were detached, and 1 mL of 50 mM phosphate buffer (pH 7.5) containing 1 mM EDTA was added. The mixture was sonicated and centrifuged at 15,000 rpm for 15 minutes, and the supernatant was used as a sample solution. To 900 μL of the sample solution, 100 μL of 9.5 mM oxidized glutathione / phosphate buffer solution and 120 μL of 2 mM NADPH / phosphate buffer solution were added, and the time-dependent change in absorbance at 340 nm (φA 340 nm / min, 3 minutes) was measured, and standard glutathione reductase was measured. The glutathione reductase activity of the sample solution was calculated from a calibration curve prepared from 0, 5, 10 and 20 mU / mL. At the same time, the protein concentration of the sample solution was measured, and the glutathione reductase activity per unit protein was calculated. The glutathione reductase activity of the cells to which no sample was added was used as a control, and the value of the glutathione reductase activity after addition of the sample when the control was 100 was calculated by the following formula 1 and used as the intracellular glutathione reductase activity.
これらの試験結果を表1に示した。サンシチニンジン抽出物には優れた細胞内グルタチオンレダクターゼの活性化作用が認められた。 The test results are shown in Table 1. Sancytin carrot extract showed excellent activation of intracellular glutathione reductase.
実験例2 使用試験
処方例1及び比較例1〜4の化粧水を用いて、軽度のニキビに悩む20代〜30代の女性75名を対象に1ヶ月間の使用試験を行った。被験者を15名ずつ5群に分け、それぞれ処方例1及び比較例1〜4の化粧水を連日朝晩の2回使用させた。試験終了後、ニキビの改善度を著しく改善:スコア3、改善:スコア2、やや改善:スコア1、不変:スコア0、増悪:スコア−1の基準で評価した。また、スティンギングの実感を調査した。
Experimental Example 2 Use Test Using the skin lotion of Formulation Example 1 and Comparative Examples 1 to 4, a use test was conducted for 1 month for 75 women in their 20s to 30s who suffer from mild acne. The test subjects were divided into 5 groups of 15 people, and the skin lotions of Prescription Example 1 and Comparative Examples 1 to 4 were used twice daily, morning and evening, respectively. After completion of the test, the degree of improvement of acne was markedly improved: score 3, improvement: score 2, slightly improved: score 1, unchanged: score 0, exacerbation: score -1. We also investigated the feeling of sting.
これらの試験結果を表2に示した。ビタミンCの誘導体を配合した比較例1の従来の化粧水1及びサンシチニンジン抽出物を配合した比較例2の従来の化粧水2を使用した群では、それぞれ比較例4の従来の化粧水4を使用した群に比べ、ニキビ改善スコアの増加が認められた。ビタミンCの誘導体を高濃度配合した比較例3の従来の化粧水3を使用した群では、さらなるニキビ改善スコアの増加がみられたが、半数以上の被験者にスティンギングの誘発がみられた。一方、ビタミンCの誘導体とサンシチニンジン抽出物とを配合した処方例1の化粧水を使用した群では、スティンギングの誘発はみられず、ビタミンCの誘導体を高濃度配合した比較例3の従来の化粧水3を使用した群を上回るニキビ改善スコアの増加がみられ、その効果は、ビタミンCの誘導体及びサンシチニンジン抽出物それぞれ単独の効果に対し、相乗的なものであった。なお、試験期間中、トラブルはひとりもなく、安全性においても問題はなかった。また、処方例2〜6についても優れたニキビ改善効果が認められ、スティンギングの誘発もみられなかった。 The test results are shown in Table 2. In the group using the conventional lotion 1 of Comparative Example 1 blended with the derivative of vitamin C and the conventional lotion 2 of Comparative Example 2 blended with the extract of sanchinin ginseng, the conventional lotion 4 of Comparative Example 4 was used. The acne improvement score was increased compared to the group using. In the group using the conventional lotion 3 of Comparative Example 3 containing a high concentration of a vitamin C derivative, the acne improvement score was further increased, but staging was induced in more than half of the subjects. On the other hand, in the group using the skin lotion of Formulation Example 1 in which a vitamin C derivative and sancinin ginseng extract were blended, no stinging was induced, and in Comparative Example 3 in which a vitamin C derivative was blended at a high concentration. The acne improvement score increased over the group using the conventional lotion 3, and the effect was synergistic with the effects of the vitamin C derivative and the sancinin ginseng extract alone. During the test period, there was no trouble and there was no problem in safety. In addition, for the prescription examples 2 to 6, an excellent acne improving effect was observed, and no induction of stinging was observed.
以上の結果より、本発明のサンシチニンジン抽出物は、グルタチオンレダクターゼ活性増強効果を示すこと、また本発明のビタミンC又はその誘導体と、サンシチニンジン抽出物とを含有することを特徴とするニキビ改善剤は、スティンギングを誘発することなく、優れたニキビ改善効果を示すことが明らかとなった。 Based on the above results, the extract of the citrus carrot of the present invention exhibits an effect of enhancing glutathione reductase activity, and also contains the vitamin C of the present invention or a derivative thereof and the extract of sanchinin carrot. It has been clarified that the improver exhibits an excellent acne improving effect without inducing stinging.
本発明のビタミンC又はその誘導体と、サンシチニンジン抽出物とを含有することを特徴とするニキビ改善剤は、スティンギングを誘発することなく、優れたニキビ改善作用を示す。 The acne-improving agent characterized by containing vitamin C of the present invention or a derivative thereof and a sancinin ginseng extract exhibits an excellent acne-ameliorating action without inducing stinging.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011186845A JP5850488B2 (en) | 2011-08-30 | 2011-08-30 | Acne improver |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011186845A JP5850488B2 (en) | 2011-08-30 | 2011-08-30 | Acne improver |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2013049634A true JP2013049634A (en) | 2013-03-14 |
JP5850488B2 JP5850488B2 (en) | 2016-02-03 |
Family
ID=48012002
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011186845A Active JP5850488B2 (en) | 2011-08-30 | 2011-08-30 | Acne improver |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5850488B2 (en) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02111710A (en) * | 1988-10-20 | 1990-04-24 | Akio Fujikawa | Cosmetic composition |
JP2002128655A (en) * | 2000-10-27 | 2002-05-09 | Nonogawa Shoji Kk | Skin-bleaching cosmetic |
JP2003155246A (en) * | 2001-11-20 | 2003-05-27 | Fancl Corp | Abirritant composition |
US20040161435A1 (en) * | 2003-02-14 | 2004-08-19 | Gupta Shyam K. | Skin Firming Anti-Aging Cosmetic Mask Compositions |
JP2004244370A (en) * | 2003-02-14 | 2004-09-02 | Pola Chem Ind Inc | External preparation for skin for pimple |
JP2005139141A (en) * | 2003-11-10 | 2005-06-02 | Nippon Menaade Keshohin Kk | Collagen synthesis promoter and external preparation for the skin |
JP2010528109A (en) * | 2007-05-31 | 2010-08-19 | 株式會社アモーレパシフィック | Skin external preparation composition containing ginseng berry extract |
-
2011
- 2011-08-30 JP JP2011186845A patent/JP5850488B2/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02111710A (en) * | 1988-10-20 | 1990-04-24 | Akio Fujikawa | Cosmetic composition |
JP2002128655A (en) * | 2000-10-27 | 2002-05-09 | Nonogawa Shoji Kk | Skin-bleaching cosmetic |
JP2003155246A (en) * | 2001-11-20 | 2003-05-27 | Fancl Corp | Abirritant composition |
US20040161435A1 (en) * | 2003-02-14 | 2004-08-19 | Gupta Shyam K. | Skin Firming Anti-Aging Cosmetic Mask Compositions |
JP2004244370A (en) * | 2003-02-14 | 2004-09-02 | Pola Chem Ind Inc | External preparation for skin for pimple |
JP2005139141A (en) * | 2003-11-10 | 2005-06-02 | Nippon Menaade Keshohin Kk | Collagen synthesis promoter and external preparation for the skin |
JP2010528109A (en) * | 2007-05-31 | 2010-08-19 | 株式會社アモーレパシフィック | Skin external preparation composition containing ginseng berry extract |
Also Published As
Publication number | Publication date |
---|---|
JP5850488B2 (en) | 2016-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8652543B2 (en) | Cosmetic and/or pharmaceutical compositions and their applications | |
KR101017709B1 (en) | Cosmetic composition comprising the herbal mixed extract comprising panax ginseng c.a meyer showing hair-growth stimulating activity and preventing activity from hair loss | |
JP2006124350A (en) | Nmf production promoter | |
JP5616045B2 (en) | Ceramide production promoter and moisturizer | |
KR20140012456A (en) | Composition for improving skin conditions comprising akebia saponin d | |
KR20210058772A (en) | Composition for treating hair loss and promoting hair growth | |
JP4824181B2 (en) | Topical skin preparation | |
JP2015124188A (en) | Sebum synthesis inhibitor | |
KR100858224B1 (en) | Cosmetic composition for the preventing loss of hair and promoting growth of hair comprising the extracts of canavalia gladiata | |
JP2007191452A (en) | Estrogen-like active agent | |
JP2006257060A (en) | TESTOSTERONE 5alpha-REDUCTASE INHIBITOR AND AGENT FOR HAIR AND SKIN CARE PREPARATION FOR DERMAL USE FORMULATED WITH THE SAME | |
JP2005023021A (en) | Elastase inhibitor | |
JP2008143827A (en) | Skin care preparation, skin-lightening agent and composition for internal use | |
JP5850488B2 (en) | Acne improver | |
KR20180101125A (en) | Cosmetic composition for skin whitening and improving skin wrinkle comprising horse oil and Rumex acetosella L. extracts | |
JP2003095857A (en) | Skin care preparation | |
JP2005194239A (en) | Ceramide synthesis promotor and skin care preparation for external use | |
JP5690149B2 (en) | External preparation or internal preparation | |
JP2005139141A (en) | Collagen synthesis promoter and external preparation for the skin | |
JP6281761B2 (en) | External preparation or internal preparation containing Hidakami Sebaya extract | |
JP5666344B2 (en) | Hair restorer | |
NL2029500B1 (en) | Cosmetic preparation using hedychium coronarium as an anti-aging skin care factor and preparation method thereof | |
WO2008125231A1 (en) | Ginsenosides and extracts containing them combined with dexpanthenol | |
JP2003342156A (en) | External preparation for skin for prevention of aging | |
JP5679251B2 (en) | Antidote or antiallergic agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20140618 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20150226 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150310 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150331 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20151006 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20151026 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20151124 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20151126 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5850488 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |